Literature DB >> 10690856

Anemia in children with cartilage-hair hypoplasia is related to body growth and to the insulin-like growth factor system.

O Mäkitie1, E Juvonen, L Dunkel, I Kaitila, M A Siimes.   

Abstract

Cartilage-hair hypoplasia (CHH) is a metaphyseal chondrodysplasia characterized by severe short-limbed short stature, hypoplastic hair, and defective immunity. The patients also have anemia. As GH may regulate both body growth and erythropoiesis, we used CHH as a clinical model to study their interrelationships. Retrospective analysis of hematological data of 114 patients showed that the severity of the anemia and macrocytosis in CHH varies with age. The anemia was most severe in early childhood. A prospective study of 21 patients with CHH showed that height correlates with hemoglobin (P = 0.006) and mean corpuscular volume of red blood cells (P < 0.0001). The individual hemoglobin levels correlated with the GH parameters [P = 0.035 for insulin-like growth factor I (IGF-I) and P = 0.002 for IGF-binding protein-3], and the mean corpuscular volume of red blood cell values correlated with fetal hemoglobin. Bone marrow cultures obtained from six patients with CHH showed reduced or totally absent erythroid colony formation, which was not influenced by GH or IGF-I in vitro or by GH treatment in vivo. In patients with CHH, we observed an association between erythropoiesis and growth. We conclude that body growth and erythropoiesis share common regulators. One of these is the GH-IGF-I axis; other factors, as not yet identified, may also be important.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10690856     DOI: 10.1210/jcem.85.2.6339

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Low hemoglobin levels in children with in idiopathic growth hormone deficiency.

Authors:  Erica A Eugster; Mark Fisch; Emily C Walvoord; Linda A DiMeglio; Ora H Pescovitz
Journal:  Endocrine       Date:  2002-07       Impact factor: 3.633

2.  Small RNAs derived from lncRNA RNase MRP have gene-silencing activity relevant to human cartilage-hair hypoplasia.

Authors:  Leslie E Rogler; Brian Kosmyna; David Moskowitz; Remon Bebawee; Joseph Rahimzadeh; Katrina Kutchko; Alain Laederach; Luigi D Notarangelo; Silvia Giliani; Eric Bouhassira; Paul Frenette; Jayanta Roy-Chowdhury; Charles E Rogler
Journal:  Hum Mol Genet       Date:  2013-09-05       Impact factor: 6.150

3.  Insulin-like growth factor-binding protein 3 and hemoglobin concentration in older persons living in the community.

Authors:  Francesco Landi; Andrea Russo; Ettore Capoluongo; Matteo Cesari; Rosa Liperoti; Paola Danese; Roberto Bernabei; Graziano Onder
Journal:  Int J Hematol       Date:  2007-05       Impact factor: 2.490

4.  Clinical and genetic distinction of Schimke immuno-osseous dysplasia and cartilage-hair hypoplasia.

Authors:  Alireza Baradaran-Heravi; Christian Thiel; Anita Rauch; Martin Zenker; Cornelius F Boerkoel; Ilkka Kaitila
Journal:  Am J Med Genet A       Date:  2008-08-01       Impact factor: 2.802

5.  Evolutionary comparison provides evidence for pathogenicity of RMRP mutations.

Authors:  Luisa Bonafé; Emmanouil T Dermitzakis; Sheila Unger; Cheryl R Greenberg; Belinda A Campos-Xavier; Andreas Zankl; Catherine Ucla; Stylianos E Antonarakis; Andrea Superti-Furga; Alexandre Reymond
Journal:  PLoS Genet       Date:  2005-10       Impact factor: 5.917

6.  Clinical and molecular diagnosis of a cartilage-hair hypoplasia with IGF-1 deficiency.

Authors:  Inma Castilla-Cortázar; Julieta Rodríguez De Ita; Irene Martín-Estal; Fabiola Castorena; Gabriel A Aguirre; Rocío García de la Garza; Martha I Elizondo
Journal:  Am J Med Genet A       Date:  2016-11-14       Impact factor: 2.802

7.  Cartilage hair hypoplasia: characteristics and orthopaedic manifestations.

Authors:  Patrick Riley; Dennis S Weiner; Bonnie Leighley; David Jonah; D Holmes Morton; Kevin A Strauss; Michael B Bober; Martin S Dicintio
Journal:  J Child Orthop       Date:  2015-03-13       Impact factor: 1.548

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.